InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,509.01
(
0.62%
)
US TECH 100
19,489.60
(
0.05%
)
Dow Jones
39,331.85
(
0.41%
)
Brent Oil
86.15
(
-0.35%
)
Bitcoin
60,329.23
(
-2.74%
)
Post# of 2342446
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

UP Trend

Send PM Follow Ignore
Followers 705
Posts 31187
Boards Moderated 0
Alias Born 01/27/2005

UP Trend

Re: None

Wednesday, 04/01/2020 11:21:41 AM

Wednesday, April 01, 2020 11:21:41 AM

Post# of 2342446
IPIX test results from RBL “demonstration of Brilacidin’s direct antiviral activity against the SARS-CoV-2 virus supports the drug’s unique 3-in-1 therapeutic potential—antiviral, anti-inflammatory, antimicrobial—to treat COVID-19 and its associated complications”
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up